 |
|
|
| |
The impact of age on the prognostic capacity of CD8+ T-cell activation during suppressive antiretroviral therapy
|
| |
| |
Reported by Jules Levin
CROI 2013
Judith J Loka,b, PhD, Peter W Huntc, MD, Ann C Collierd, MD, Constance A Bensone, MD, Mallory D Wittf, MD, Amneris E Luqueg, MD, Steven G Deeksh, MD, Ronald J Boschb, PhD
aHarvard School of Public Health, Boston, Massachusetts, bCenter for Biostatistics in AIDS Research, Harvard School of Public Health, Boston, Massachusetts, cSFGH HIV/AIDS Division, University of California, San Francisco, California, dUniversity of Washington School of Medicine, Seattle, Washington, eUniversity of California, San Diego, California, fDavid Geffen School of Medicine at UCLA and the Los Angeles Biomedical Institute of Research at Harbor-UCLA, Los Angeles, California, gUniversity of Rochester Medical Center, Rochester, New York, hUniversity of California, San Francisco, California
|
| |
|
|
|
|
|
